Breaking News Instant updates and real-time market news.

SHLD

Sears

$1.13

-0.055 (-4.66%)

, M

Macy's

$37.72

0.16 (0.43%)

11:17
08/23/18
08/23
11:17
08/23/18
11:17

Strong consumer sentiment breathes life into 'left for dead retailers,' WSJ says

Shares of "left for dead retailers" are in the midst of a recovery due to strong U.S. consumer sentiment, says the Wall Street Journal. After Target (TGT) reported its quarterly results this week, its CEO Brian Cornell said, "Like others, we're currently benefiting from a very strong consumer environment, perhaps the strongest I've seen in my career." Publicly traded companies in the space include J.C. Penney (JCP), Kohl's (KSS), Macy's (M), Nordstrom (JWN) and Sears (SHLD). Reference Link

SHLD

Sears

$1.13

-0.055 (-4.66%)

M

Macy's

$37.72

0.16 (0.43%)

JWN

Nordstrom

$61.17

0.61 (1.01%)

JCP

J.C. Penney

$1.79

-0.01 (-0.56%)

KSS

Kohl's

$80.25

1.275 (1.61%)

TGT

Target

$86.62

0.66 (0.77%)

  • 17

    Sep

  • 28

    Oct

SHLD Sears
$1.13

-0.055 (-4.66%)

05/09/18
JEFF
05/09/18
NO CHANGE
Target $60
JEFF
Hold
Sears-Amazon tire partnership not a negative for Monro, says Jefferies
Jefferies analyst Bret Jordan kept his Hold rating and $60 price target on Monro (MNRO) after its stock price fell over 7.5% today to $52.70, saying Sears (SHLD) partnership with Amazon (AMZN) on tire installation and services is a not "transformational negative". Jordan notes that the greater transparency and price matching is not new, while Monro is "already an installer for other online sellers such as Tirerack and ATD's tirebuyer.com". The analyst adds that the agreement is not exclusive, leaving the "door open" for Monro to enter into a similar deal.
01/16/18
LOOP
01/16/18
NO CHANGE
Target $80
LOOP
Buy
Best Buy price target raised to $80 from $72 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on Best Buy (BBY) to $80, noting a more optimistic outlook for the stock thanks to some recent developments. The analyst cites strong November-December U.S. retail sales reports, PC shipments rising in Q4 for the first time in six years, and some closures of stores by Sears Holdings (SHLD) and Wal-Mart's (WMT) Sam's Club. Chukumba keeps his Buy rating on Best Buy.
02/05/18
JEFF
02/05/18
NO CHANGE
Target $100
JEFF
Buy
Bon-Ton Stores bankruptcy benefits Kohl's, says Jefferies
Jefferies analyst Randal Konik notes that Bon-Ton Stores filed bankruptcy protection and provided the locations of the about 50 units slated for closure. The analyst now estimates near-term closures from Macy's (M), Sears (SHLD), Kmart, and Bon-Ton (BONT) should add about 18c to Kohl's (KSS) EPS and a 1.5% comp lift. Moreover, Konik believes the materialization of Bon-Ton's closures could be a "cherry on top" to accelerating fundamentals at Kohl's this year. He reiterates a Buy rating and $100 price target on Kohl's shares.
04/19/18
MSCO
04/19/18
NO CHANGE
Target $1550
MSCO
Overweight
Amazon gaining apparel market share in U.S., says Morgan Stanley
Morgan Stanley analyst Brian Nowak said his analysis shows that Amazon (AMZN) gained 1.5% of U.S. apparel market share in 2017, largely at the expense of department stores. He estimates Amazon is the second largest U.S. apparel retailer, trailing only Walmart (WMT), and expects the e-commerce giant to take the number one spot in terms of U.S. apparel market share in 2018. Cumulatively, Nowak estimates Sears (SHLD), Macy's (M) and J.C. Penney (JCP) lost 0.8% share in 2017, with shareholdings remaining roughly flat for Target (TGT) and Kohl's (KSS). He maintains an Overweight rating and $1,550 price target on Amazon shares.
M Macy's
$37.72

0.16 (0.43%)

08/16/18
DBAB
08/16/18
NO CHANGE
Target $35
DBAB
Hold
Macy's results not enough to change negative sentiment, says Deutsche Bank
Deutsche Bank analyst Paul Trussell maintained a Hold rating on Macy's but raised his price target to $35 from $33 following the company's "solid" Q2 results, which he says are "not enough to change negative investor sentiment," as many retailers face tough compares in 2H and an unfavorable calendar while having lofty valuations. While he comments management on delivering solid improvement in the quarter, Trussell believes valuation had become stretched into the print, leaving little room for error.
08/16/18
RBCM
08/16/18
NO CHANGE
Target $39
RBCM
Sector Perform
Macy's sell-off is 'the function of profit taking', says RBC Capital
RBC Capital analyst Brian Tunick kept his Sector Perform rating and $39 price target on Macy's after its Q2 results, saying the earnings were "solid" and the outlook for the rest of FY18 was encouraging. The analyst believes that the selloff after the results was a "function of profit taking", with the stock having risen about 70% year-to-date, along with a more challenging comparisons in the second half of the year. Tunick states that he expects Macy's business momentum and initiatives to allow it to achieve its FY18 guidance.
08/16/18
SBSH
08/16/18
NO CHANGE
SBSH
Sell
Citi says nothing in Macy's quarter alters view of structural pressures
Citi analyst Paul Lejuez said Macy's comp growth in Q2 was "certainly better than the negative comps we've seen for years," but he added that its earnings beat came mostly from credit income, asset sales and taxes rather than the core retail business. Given tougher upcoming comparisons, he is concerned the company may fall short of its raised second half guidance on the top-line, added Lejuez, who said nothing in this quarter alters his view that the company faces long-term structural pressures. He maintains a Sell rating on Macy's shares.
08/15/18
JEFF
08/15/18
NO CHANGE
JEFF
Hold
Macy's shares 'stuck in neutral,' says Jefferies
Jefferies analyst Randal Konik said Macy's Q2 was decent, but expectations were high as gross margins were not as high as the Street had hoped. Konik believes Macy's shares remain stuck in neutral after recent strength and remains Hold rated.
JWN Nordstrom
$61.17

0.61 (1.01%)

08/17/18
RBCM
08/17/18
NO CHANGE
Target $55
RBCM
Sector Perform
Nordstrom price target raised to $55 from $49 at RBC Capital
RBC Capital analyst Brian Tunick raised his price target on Nordstrom to $55 and kept his Sector Perform rating after its "very solid" Q2 earnings report that showed a "notable acceleration" in comps along with margin improvement. The analyst adds that he is encouraged by the company's e-commerce growth, with "improvements in off-price" contributing to the best comps in 3 years. Tunick expects the positive comps and merchandise margin trends to be sustained.
08/17/18
NOMU
08/17/18
NO CHANGE
Target $59
NOMU
Neutral
Nordstrom price target raised to $59 from $54 at Nomura Instinet
Nomura analyst Simeon Siegel maintained a Neutral rating on Nordstrom but raised his price target for shares to $59 from $54, telling investors in a research note that the retailer showed strength at its high and low end in Q2. Siegel says that with a quarter of "moving pieces," gross margin was "noisy" but strong, which layered onto a raised FY EPS guide and his belief that EPS has material upside from an unappreciated buyback plan could drive shares higher.
08/17/18
DBAB
08/17/18
NO CHANGE
Target $61
DBAB
Buy
Nordstrom price target raised to $61 from $56 at Deutsche Bank
Deutsche Bank analyst Paul Trussell backed a Buy rating on Nordstrom and raised his price target to $61, telling investors that while the company posted a Q2 beat and raise, the real highlight for Q2 was the "remarkably strong" comp of 4%. Trussell believes NOrdstrom will continue to gain share and drive "solid" comp growth, coupled with an operating margin that is forecast to expand through fiscal 2022 after years of contraction.
08/17/18
UBSW
08/17/18
NO CHANGE
Target $73
UBSW
Buy
UBS says conviction in Nordstrom increasing following Q2 results
UBS analyst Jay Sole said the Nordstrom Q2 beat and raise results increased his conviction in his buy rating. The analyst noted the company raised its EBIT guidance and he believes this represents signs of an early EBIT margin inflection. He said the Q2 results are likely a first step in multi-year improvement process. Sole reiterated his Buy rating and raised his price target to $73 from $69 on Nordstrom shares.
JCP J.C. Penney
$1.79

-0.01 (-0.56%)

08/16/18
JPMS
08/16/18
DOWNGRADE
JPMS
Underweight
J.C. Penney downgraded to Underweight from Neutral at JPMorgan
08/16/18
BOFA
08/16/18
DOWNGRADE
BOFA
Underperform
J.C. Penney downgraded to Underperform from Neutral at BofA/Merrill
08/16/18
FBCO
08/16/18
NO CHANGE
Target $1
FBCO
J.C. Penney price target cut to $1 from $2 at Credit Suisse
08/17/18
SBSH
08/17/18
NO CHANGE
Target $0.5
SBSH
Sell
J.C. Penney price target lowered to 50c from $2 at Citi
Citi analyst Paul Lejuez said that J.C. Penney " finds itself in a very difficult position" following its Q2 report given that they lack a CEO and head merchant and are struggling at a time when peers are seeing improvement in their business. While he does not see near-term liquidity issues, Lejuez said there is not that much equity value given the company's high debt load. He lowered his price target on J.C. Penney shares to 50c from $2 and keeps a Sell rating on the stock.
KSS Kohl's
$80.25

1.275 (1.61%)

08/22/18
MKMP
08/22/18
NO CHANGE
Target $81
MKMP
Neutral
Kohl's price target raised to $81 from $63 at MKM Partners
MKM Partners analyst Patrick McKeever raised his price target on Kohl's to $81 after a "very good" Q2, saying its comps were modestly better than expected and gross margins were strong as the company maintained a "lean inventory" in the quarter. While acknowledging that he missed the stock's 45% year-to-date run, McKeever adds that he remains concerned about Kohl's store traffic which he estimates to be negative. The analyst also anticipates comps to slow in the second half of the year against more difficult compares, keeping his Neutral rating on Kohl's.
08/22/18
RBCM
08/22/18
NO CHANGE
Target $82
RBCM
Sector Perform
Kohl's price target raised to $82 from $69 at RBC Capital
RBC Capital analyst Brian Tunick raised his price target on Kohl's to $82 after its "robust" Q2 results and "strong" comps thanks to the company's product and marketing initiatives along with a gross margin recovery coming from its "tight inventory management". The analyst states that he is more confident in Kohl's ongoing sales improvements and favorable macro environment combining to achieve an upside to the company's guidance. Tunick also keeps a Sector Perform rating on the shares, noting that the growing "secular pressures make a more meaningful comp recovery unlikely".
08/23/18
MSCO
08/23/18
NO CHANGE
Target $51
MSCO
Underweight
Kohl's price target raised to $51 from $45 at Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger maintained an Underweight rating on Kohl's but raised her price target to $51 from $45 following the company's Q2 earnings report, telling investors in a research note that Kohl's delivered an "excellent" 12 EPS beat, and its "clean" inventory bodes well for gross margin going forward. However, Greenberger wonders whether management set the comp bar too high for the second half of the year and is concerned about the lack of traffic growth driving the comp.
08/20/18
DBAB
08/20/18
NO CHANGE
Target $175
DBAB
Buy
Deutsche Bank says 'sticking with' off-price, athletic brands in apparel space
Deutsche Bank analyst Paul Trussell previewed earnings for apparel companies, telling investors in a research note that he is "sticking with" off-price, the brands and athletic brands over specialty retailers and department stores. Trussell expects beats from Burlington Stores (BURL), Ross Stores (ROST), TJX (TJX), PVH (PVH), Foot Locker (FL) and Lululemon (LULU), along with American Eagle Outfitters (AEO) and Buckle (BKE) as the outliers in the specialty group and Kohl's (KSS), and says he is "a bit more cautious" for the frest of his apparel coverage given stretched valuations. Trussell raised his price target for Burlington Stores to $175 from $167, to $96 from $91 for Ross and to $105 from $100 fro TJX, but cut his price target to $171 from $176 for PVH.
TGT Target
$86.62

0.66 (0.77%)

08/23/18
LEHM
08/23/18
NO CHANGE
Target $90
LEHM
Equal Weight
Target price target raised to $90 from $70 at Barclays
Barclays analyst Matthew McClintock raised his price target for Target to $90 saying that while he's not yet ready to become bullish on the story, he finds it "very difficult to ignore the exceptionally strong traffic results over the past several quarters." This may signal a "structural inflection point in the story," McClintock tells investors in a research note following Target's Q2 results. The analyst keeps an Equal Weight rating on the name.
08/23/18
WOLF
08/23/18
DOWNGRADE
WOLF
Peer Perform
Target downgraded to Peer Perform from Outperform at Wolfe Research
08/23/18
08/23/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Outperform from Market Perform at Telsey Advisory. 2. Deckers Brands (DECK) upgraded to Neutral from Negative at Susquehanna with analyst Sam Poser saying wholesale accounts are more positive than just a few months ago following checks with both large and small retailers. 3. Nielsen (NLSN) upgraded to Neutral from Sell at Goldman Sachs with analyst George Tong saying with activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, he sees increased likelihood of Nielsen being involved in a transaction. 4. Finisar (FNSR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Troy Jensen saying China demand is returning via Huawei and ZTE (ZTCOY), Finisar is facing easy comps following five quarters of depressed demand and the upcoming 400G cycle should provide a tailwind in 2019. 5. Coca-Cola Amatil (CCLAY) upgraded to Equal Weight from Underweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.

TODAY'S FREE FLY STORIES

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$48.17

0.84 (1.77%)

17:26
02/15/19
02/15
17:26
02/15/19
17:26
Hot Stocks
Mondelez to transfer listing of debt securities to Nasdaq »

Mondelez International,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 06

    Mar

  • 28

    May

FN

Fabrinet

$55.23

0.67 (1.23%)

17:25
02/15/19
02/15
17:25
02/15/19
17:25
Hot Stocks
Fabrinet CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

UBER

Uber

$0.00

(0.00%)

17:24
02/15/19
02/15
17:24
02/15/19
17:24
Periodicals
Uber sues NYC over move to cap number of ride-hailing drivers, Bloomberg says »

Uber is suing New York…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

17:19
02/15/19
02/15
17:19
02/15/19
17:19
Periodicals
House Democrats to probe POTUS emergency declaration, Bloomberg says »

The House Judiciary…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.40

2.93 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$51.71

0.25 (0.49%)

17:11
02/15/19
02/15
17:11
02/15/19
17:11
Hot Stocks
Oracle authorizes additional $12B stock buyback under existing program »

In a regulatory 8K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

SBLK

Star Bulk Carriers

$8.21

0.13 (1.61%)

17:03
02/15/19
02/15
17:03
02/15/19
17:03
Hot Stocks
Star Bulk Carriers acquires 95,605 of its common shares »

Star Bulk Carriers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLI

Hollysys

$20.56

0.26 (1.28%)

17:02
02/15/19
02/15
17:02
02/15/19
17:02
Earnings
Hollysys reports Q2 adjusted EPS 73c, consensus 59c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

AKS

AK Steel

$2.98

-0.015 (-0.50%)

16:58
02/15/19
02/15
16:58
02/15/19
16:58
Syndicate
Breaking Syndicate news story on AK Steel »

AK Steel files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
02/15/19
02/15
16:55
02/15/19
16:55
General news
Treasury Market Summary: i »

Treasury Market Summary:…

LPTX

Leap Therapeutics

$1.65

(0.00%)

16:53
02/15/19
02/15
16:53
02/15/19
16:53
Hot Stocks
Valence Helix Investments discloses 10.99% stake in Leap Therapeutics »

Valence Helix disclosed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$23.25

-0.24 (-1.02%)

16:52
02/15/19
02/15
16:52
02/15/19
16:52
Hot Stocks
Mid Penn Bancorp seeks approval to relocate Allentown Boulevard branch »

Mid Penn Bank, subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$423.79

8.54 (2.06%)

, AMGN

Amgen

$188.31

1.6 (0.86%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
Regeneron says EPO revokes Immunex's European patent No. 2,990,420 »

Regeneron…

REGN

Regeneron

$423.79

8.54 (2.06%)

AMGN

Amgen

$188.31

1.6 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 28

    Apr

  • 13

    May

UPS

UPS

$110.89

-0.91 (-0.81%)

16:44
02/15/19
02/15
16:44
02/15/19
16:44
Hot Stocks
UPS CFO sells 9.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.